Previous immunological characterization of CD8 T cells indicated that DHX37 suppressed effector functions, cytokine production, and T cell activation by modulating NF-κB [19], which first showed that DHX37 was related to the progression of cancers. The gene discussed is DHX37; the disease is cancer.